AI is changing how we answer the first question on every trial: can this be done, where and how fast?
This is what AI-Augmented feasibility looks like at TFS.
Feasibility sets the trajectory of every trial. Get the country mix wrong, miss a site, underestimate competitive density and a Phase II slips by six months before it has started. The pressure to get it right and get it fast, has always been there. Now the tools to do both exist.
TFS HealthScience has integrated AI into its feasibility methodology not to replace the judgement that makes a recommendation rigorous, but to remove the bottleneck that slows it down.
In this case study you will find:
- Where AI runs and where experienced feasibility leads take over
- How 4 in 5 feasibilities in 2026 used this approach to deliver a 35% faster turnaround
The result is a faster path from a sponsor’s first question to a credible answer and a faster trial.
Download the case study to see how it works.
Connect with Us
Contact us today to discover how TFS can be your strategic CRO partner in clinical development.
Latest resources
Getting real-world evidence to the sponsor before the deadline, not after
Getting real-world evidence to the sponsor before the deadline, not after
AI is changing how we answer the first question on every trial: can this be done, where and how fast?
AI is changing how we answer the first question on every trial: can this be done, where and how fast?
10 oncology trial readouts to watch for at ASCO 2026